Advertisement

Loading...

Suzuken Co., Ltd.

SZUKFPNK
Healthcare
Medical - Distribution
$30.30
$0.00(0.00%)
U.S. Market opens in 13h 28m

Suzuken Co., Ltd. Fundamental Analysis

Suzuken Co., Ltd. (SZUKF) shows weak financial fundamentals with a PE ratio of 9.59, profit margin of 1.43%, and ROE of 8.65%. The company generates $1997.7B in annual revenue with weak year-over-year growth of 0.56%.

Key Strengths

Cash Position10349.41%
PEG Ratio0.00

Areas of Concern

ROE8.65%
Operating Margin1.41%
We analyze SZUKF's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of 35.7/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
35.7/100

We analyze SZUKF's fundamental strength across five key dimensions:

Efficiency Score

Weak

SZUKF struggles to generate sufficient returns from assets.

ROA > 10%
2.68%

Valuation Score

Excellent

SZUKF trades at attractive valuation levels.

PE < 25
9.59
PEG Ratio < 2
0.00

Growth Score

Moderate

SZUKF shows steady but slowing expansion.

Revenue Growth > 5%
0.56%
EPS Growth > 10%
27.02%

Financial Health Score

Excellent

SZUKF maintains a strong and stable balance sheet.

Debt/Equity < 1
0.05
Current Ratio > 1
1.19

Profitability Score

Weak

SZUKF struggles to sustain strong margins.

ROE > 15%
8.65%
Net Margin ≥ 15%
1.43%
Positive Free Cash Flow
No

Key Financial Metrics

Is SZUKF Expensive or Cheap?

P/E Ratio

SZUKF trades at 9.59 times earnings. This suggests potential undervaluation.

9.59

PEG Ratio

When adjusting for growth, SZUKF's PEG of 0.00 indicates potential undervaluation.

0.00

Price to Book

The market values Suzuken Co., Ltd. at 0.83 times its book value. This may indicate undervaluation.

0.83

EV/EBITDA

Enterprise value stands at 8.44 times EBITDA. This is generally considered low.

8.44

How Well Does SZUKF Make Money?

Net Profit Margin

For every $100 in sales, Suzuken Co., Ltd. keeps $1.43 as profit after all expenses.

1.43%

Operating Margin

Core operations generate 1.41 in profit for every $100 in revenue, before interest and taxes.

1.41%

ROE

Management delivers $8.65 in profit for every $100 of shareholder equity.

8.65%

ROA

Suzuken Co., Ltd. generates $2.68 in profit for every $100 in assets, demonstrating efficient asset deployment.

2.68%

Following the Money - Real Cash Generation

Operating Cash Flow

Suzuken Co., Ltd. generates limited operating cash flow of $0.00, signaling weaker underlying cash strength.

$0.00

Free Cash Flow

Suzuken Co., Ltd. generates weak or negative free cash flow of $0.00, restricting financial flexibility.

$0.00

FCF Per Share

Each share generates $0.00 in free cash annually.

$0.00

FCF Yield

SZUKF converts 0.00% of its market value into free cash.

0.00%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

9.59

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

0.003

vs 25 benchmark

P/B Ratio

Price to book value ratio

0.83

vs 25 benchmark

P/S Ratio

Price to sales ratio

0.11

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.05

vs 25 benchmark

Current Ratio

Current assets to current liabilities

1.19

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

0.09

vs 25 benchmark

ROA

Return on assets percentage

0.03

vs 25 benchmark

ROCE

Return on capital employed

0.08

vs 25 benchmark

How SZUKF Stacks Against Its Sector Peers

MetricSZUKF ValueSector AveragePerformance
P/E Ratio9.5928.31 Better (Cheaper)
ROE8.65%699.00% Weak
Net Margin1.43%-130884.00% (disorted) Weak
Debt/Equity0.050.34 Strong (Low Leverage)
Current Ratio1.192775.16 Neutral
ROA2.68%-14469.00% (disorted) Weak

SZUKF outperforms its industry in 2 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Suzuken Co., Ltd.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

29.92%

Industry Style: Defensive, Growth, Innovation

High Growth

EPS CAGR

46.51%

Industry Style: Defensive, Growth, Innovation

High Growth

FCF CAGR

-202.06%

Industry Style: Defensive, Growth, Innovation

Declining

Fundamental Analysis FAQ